• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI Roundup
  • Pharma
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI Roundup
  • Pharma
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Cardiology

Liraglutide significantly reduces risk for major cardiac events in elderly patients with diabetes

byCaitlyn HuiandDeepti Shroff Karhade
December 5, 2018
in Cardiology, Chronic Disease, Endocrinology
Reading Time: 2 mins read
0
Share on FacebookShare on Twitter

1. A significant reduction in major cardiac events among elderly patients was seen in the liraglutide treatment group.

2. The risk reduction of adverse cardiac events in the liraglutide treatment group seemed to vary with age. 

Evidence Rating Level: 2 (Good)

Study Rundown: Type 2 diabetes mellitus (T2DM) continues to increase in prevalence among older adults, with significant associated morbidity and mortality. Liraglutide is among some of the newer treatments for diabetes and works through a glucagon-like peptide-1 agonist mechanism. This class of drugs has increased glycemic efficacy, with decreased risk for hypoglycemia compared to some other treatment options. The authors of this study examined the cardiovascular effects of liraglutide compared to placebo in older patients, finding that liraglutide significantly reduces the risk for major cardiac events in elderly patients with diabetes. The main limitation of this study was a short follow-up period and a smaller cohort of patients in the age category inclusive of adults aged 75 and up. Overall, this study suggests that liraglutide could be a beneficial treatment for elderly diabetic patients for reducing the risk of cardiac events.

Click to read the study in Annals of Internal Medicine

Relevant Reading: Liraglutide for weight management: a critical review of the evidence

RELATED REPORTS

Semaglutide may improve cardiovascular outcomes versus empagliflozin in patients with diabetes

Oral semaglutide reduces cardiovascular event rates in high-risk patients

Semaglutide improves walking ability in patients with peripheral artery disease and type 2 diabetes

In-Depth [randomized controlled trial]: In this post-hoc analysis of the LEADER trial the authors assessed the effects of liraglutide on cardiovascular outcomes of patients aged 75 and older, ages 60 to 74 and younger than 60 years. The study’s safety end points included the frequency of serious adverse events and medical events of special interest. When comparing the treatment group to the placebo group, there were no significant differences in adverse events regardless of age category. However, there were higher numbers of adverse events in the older age group generally. The calculated risk reduction of all-cause death with liraglutide compared to placebo in patients aged 75 years and older was 35% and 34% for major adverse cardiac events. This number was significantly lower for patients aged 60 to 74, where the risk reduction was 6% (P for interaction = 0.088) for all-cause death.

Image: PD

©2018 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: cardiovascular diseaseMACEType 2 Diabetes Mellitus
Previous Post

Proton pump inhibitor co-therapy reduces gastrointestinal bleeding risk of oral anticoagulants

Next Post

Renin-angiotensin inhibitors may reduce mortality and heart failure readmissions in patients with transcatheter aortic valve replacement

RelatedReports

Compliance-linked incentives increase infant immunizations rates in rural India
Endocrinology

Semaglutide may improve cardiovascular outcomes versus empagliflozin in patients with diabetes

June 16, 2025
Mediterranean diet linked to reduced diabetes risk in high risk cardiovascular patients
Cardiology

Oral semaglutide reduces cardiovascular event rates in high-risk patients

June 5, 2025
Increased number of daily steps linked with decreased mortality in older women
Chronic Disease

Semaglutide improves walking ability in patients with peripheral artery disease and type 2 diabetes

May 29, 2025
Quick Take: Effect of Pregabalin on Radiotherapy-Related Neuropathic Pain in Patients With Head and Neck Cancer: A Randomized Controlled Trial
Chronic Disease

Increased tirzepatide use for glycemic and weight control since United States market entry

April 14, 2025
Next Post
Quick Take: Association of African Ancestry with Electrocardiographic Voltage and Concentric Left Ventricular Hypertrophy: The Dallas Heart Study

Renin-angiotensin inhibitors may reduce mortality and heart failure readmissions in patients with transcatheter aortic valve replacement

Large spike in drug use-associated infective endocarditis linked with opioid epidemic

Large spike in drug use-associated infective endocarditis linked with opioid epidemic

Pediatric palliative care outcome measures often miss quality of life

Pediatric palliative care outcome measures often miss quality of life

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Seventh cervical nerve neurotomy may augment speech therapy in patients with chronic aphasia post-stroke
  • Time-restricted eating does not confer changes in sleep, mood, or quality of life
  • Commonly cited medication triggers may not increase risk of microscopic colitis among older adults
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI Roundup
  • Pharma
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
No Result
View All Result

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.